乾性角結膜炎(ドライアイ)：世界の治験レビュー（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Keratoconjunctivitis sicca (Dry Eye) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Keratoconjunctivitis sicca (Dry Eye) 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Novartis AG 33
Clinical Trial Overview of Novartis AG 33
Allergan, Inc. 37
Clinical Trial Overview of Allergan, Inc. 37
Santen Pharmaceutical Co., Ltd. 40
Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 40
Valeant Pharmaceuticals International, Inc. 42
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 42
Innovative Medical Products 43
Clinical Trial Overview of Innovative Medical Products 43
Otsuka Holdings Co., Ltd. 44
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 44
Merck & Co., Inc. 45
Clinical Trial Overview of Merck & Co., Inc. 45
ORA, Inc. 46
Clinical Trial Overview of ORA, Inc. 46
Pfizer Inc. 47
Clinical Trial Overview of Pfizer Inc. 47
Laboratoires Thea S.A. 48
Clinical Trial Overview of Laboratoires Thea S.A. 48
Clinical Trial Overview of Top Institutes / Government 49
Kyoto Prefectural University of Medicine 49
Clinical Trial Overview of Kyoto Prefectural University of Medicine 49
Keio University 50
Clinical Trial Overview of Keio University 50
University of Texas Southwestern Medical Center at Dallas 51
Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 51
Marshall B. Ketchum University 52
Clinical Trial Overview of Marshall B. Ketchum University 52
Federal University of Sao Paulo 53
Clinical Trial Overview of Federal University of Sao Paulo 53
Massachusetts Eye and Ear Infirmary 54
Clinical Trial Overview of Massachusetts Eye and Ear Infirmary 54
Ophthalmic Consultants of Long Island 55
Clinical Trial Overview of Ophthalmic Consultants of Long Island 55
Instituto Universitario de Oftalmobiología Aplicada 56
Clinical Trial Overview of Instituto Universitario de Oftalmobiología Aplicada 56
Wenzhou Medical College 57
Clinical Trial Overview of Wenzhou Medical College 57
Marui Eye Clinic 58
Clinical Trial Overview of Marui Eye Clinic 58
Five Key Clinical Profiles 59
Appendix 83
Abbreviations 83
Definitions 83
Research Methodology 84
Secondary Research 85
About GlobalData 85
Contact Us 85
Disclaimer 85
Source 86